1834 Investment Advisors’s GSK GSK Stock Holding History

1834 Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-648	Closed	-$35K	–	304
2022 Q2	$35K	Hold	648	–	–	﹤0.01%	296
2022 Q1	$35K	Hold	648	–	–	﹤0.01%	270
2021 Q4	$36K	Hold	648	–	–	﹤0.01%	284
2021 Q3	$31K	Hold	648	–	–	﹤0.01%	302
2021 Q2	$32K	Hold	648	–	–	﹤0.01%	308
2021 Q1	$29K	Hold	648	–	–	﹤0.01%	297
2020 Q4	$30K	Hold	648	–	–	﹤0.01%	294
2020 Q3	$30K	Hold	648	–	–	﹤0.01%	287
2020 Q2	$33K	Hold	648	–	–	0.01%	265
2020 Q1	$31K	Hold	648	–	–	0.01%	278
2019 Q4	$38K	Hold	648	–	–	0.01%	291
2019 Q3	$35K	Hold	648	–	–	0.01%	296
2019 Q2	$32K	Hold	648	–	–	﹤0.01%	310
2019 Q1	$34K	Hold	648	–	–	0.01%	303
2018 Q4	$31K	Hold	648	–	–	0.01%	299
2018 Q3	$33K	Hold	648	–	–	﹤0.01%	302
2018 Q2	$33K	Hold	648	–	–	0.01%	301
2018 Q1	$32K	Hold	648	–	–	0.01%	309
2017 Q4	$29K	Buy	+648	New	+$29.9K	﹤0.01%	333
2015 Q3	–	Sell	-4,289	Closed	-$223K	–	198
2015 Q2	$223K	Sell	4,289 -3,398	-44%	-$191K	0.06%	146
2015 Q1	$443K	Sell	7,687 -1,099	-13%	-$63K	0.12%	116
2014 Q4	$469K	Sell	8,786 -650	-7%	-$36.4K	0.13%	110
2014 Q3	$542K	Hold	9,436	–	–	0.15%	104
2014 Q2	$631K	Buy	9,436 +352	+4%	+$23.8K	0.17%	102
2014 Q1	$607K	Sell	9,084 -1,626	-15%	-$110K	0.18%	94
2013 Q4	$715K	Sell	10,710 -316	-3%	-$20.5K	0.21%	94
2013 Q3	$691K	Sell	11,026 -752	-6%	-$48.4K	0.23%	87
2013 Q2	$736K	Buy	+11,778	New	+$748K	0.25%	83

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

1834 Investment Advisors's GSK Position: Q3 2022 in Review

1834 Investment Advisors sold out of GSK (GSK) in Q3 2022, closing a stake of 648 shares — an estimated $35K sold.

1834 Investment Advisors first reported a position in GSK in Q2 2013 and held it in 28 quarters. The position peaked at $736K in Q2 2013. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

1834 Investment Advisors reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
1834 Investment Advisors sold 648 GSK shares in Q3 2022, an estimated $35K.
1834 Investment Advisors first reported a position in GSK in Q2 2013 and held it in 28 quarters.
1834 Investment Advisors's GSK position peaked at $736K in Q2 2013.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on 1834 Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.